Adrenal function in relation to cytokines and outcome in non-critically ill patients with COVID-19.
N AthanasiouA DiamantopoulosC KeskinidouP KatsaounouA AngelousiE JahajP MourelatosC S VrettouE BotoulaA G VassiliouA KotanidouS TsagarakisI DimopoulouDimitra-Argyro VassiliadiPublished in: Journal of endocrinological investigation (2023)
Our findings indicate that cortisol serves as an indicator of disease severity. GILZ expression appears to be a more effective marker of mortality prediction in moderate COVID-19 cases. However, routine measurement of GILZ levels is currently unavailable. Elevated levels of cortisol may be indicative of patients with moderate COVID-19 who are at a higher risk of deterioration. This information can aid in identifying individuals who require early medical attention.